GlassScriptPhysician profile
Andrew Medvedovsky
NPI 1649431594
$32,012.28
in general payments reported to CMS, 2019-2025
38 companies · $1,348 in 2025
The $1,348 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.72 · 2020: $240 · 2021: $1,333 · 2022: $2,938 · 2023: $25K · 2024: $1,375 · 2025: $1,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $5,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,000.00 |
| Food and Beverage | $5,405.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $15,571.42 | 2022-2023 | Mild Device Kit |
| Spinal Simplicity, LLC | $6,635.47 | 2022-2024 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $2,816.78 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Bionic Navigator |
| Nutech Spine, INC. | $2,500.00 | 2023 | Sifix |
| Medtronic, INC. | $1,427.15 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Collegium Pharmaceutical, INC. | $565.60 | 2020-2025 | Xtampza, Belbuca |
| Nevro Corp. | $295.35 | 2020-2024 | Senza |
| Abbott Laboratories | $292.82 | 2021-2024 | Eterna, Proclaim |
| Foundation Fusion Solutions, LLC | $218.15 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.52 | 2023-2025 | Relistor |
| Stimwave Technologies Incorporated | $145.84 | 2020-2022 | |
| Si-Bone, INC. | $111.95 | 2023-2024 | |
| Medtronic USA, INC. | $111.60 | 2019-2020 | |
| Pfizer INC. | $103.31 | 2023-2025 | |
| Abbvie INC. | $95.52 | 2021-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $89.38 | 2021-2022 | |
| Globus Medical, INC. | $77.43 | 2025 | Sable, Senza |
| Virtus Pharmaceuticals LLC | $72.87 | 2021 | |
| Scilex Pharmaceuticals INC. | $69.36 | 2022-2023 | Ztlido |
| Relievant Medsystems, INC. | $62.72 | 2023 | Intracept |
| Saluda Medical Americas, INC. | $61.67 | 2025 | Evoke |
| Painteq LLC | $57.00 | 2023-2024 | Painteq |
| Bioventus LLC | $52.37 | 2021-2024 | Gelsyn-3 |
| Alevio, LLC | $50.99 | 2023 | Sicure Sacroiliac Joint Fusion System |
| Camber Spine Technologies LLC | $47.75 | 2021 | |
| Biodelivery Sciences International, INC. | $41.56 | 2021 | |
| Depuy Synthes Sales INC. | $38.58 | 2023 | Monovisc, Orthovisc |
| Zavation Medical Products, LLC | $36.70 | 2023 | |
| Biotronik Nro, INC. | $29.97 | 2025 | Prospera |
| Vertex Pharmaceuticals Incorporated | $29.82 | 2025 | |
| Hydrocision, INC. | $28.09 | 2024 | Tenjet |
| Axsome Therapeutics, INC. | $23.30 | 2025 | Symbravo |
| Protega Pharmaceutials INC | $23.04 | 2022 | |
| Redhill Biopharma INC. | $17.40 | 2021 | |
| Curonix LLC | $16.47 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Hikma Pharmaceuticals USA | $14.38 | 2022 | |
| Valinor Pharma, LLC | $13.69 | 2024 | Movantik |
| Convatec INC. | $13.26 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Medvedovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.